|
N30 Pharmaceuticals - Product Pipeline Review' provides data on the N30 Pharmaceuticals’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, N30 Pharmaceuticals’s corporate website, SEC filings, investor presentations and featured press releases, both from N30 Pharmaceuticals and industry-specific third party sources, put together by Global Markets Direct’s team. Scope - N30 Pharmaceuticals - Brief N30 Pharmaceuticals overview including business description, key information and facts, and its locations and subsidiaries. - Review of current pipeline of N30 Pharmaceuticals human therapeutic division. - Overview of pipeline therapeutics across various therapy areas. - Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe. - Product profiles for late stage and clinical stage products of N30 Pharmaceuticals with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones. - Recent updates of the N30 Pharmaceuticals’s pipeline in the last quarter. - Key discontinued and dormant projects. - Latest news and deals relating to the products. Reasons to buy - Evaluate N30 Pharmaceuticals’s strategic position with total access to detailed information on its product pipeline. - Assess the growth potential of N30 Pharmaceuticals in its therapy areas of focus. - Identify new drug targets and therapeutic classes in the N30 Pharmaceuticals’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas. - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps. - Exploit collaboration and partnership opportunities with N30 Pharmaceuticals. - Avoid Intellectual Property Rights related issues. - Explore the dormant and discontinued projects of N30 Pharmaceuticals and identify potential opportunities in those areas. Table of contents : Table of Contents 2 List of Tables 4 List of Figures 4 N30 Pharmaceuticals Snapshot 5 N30 Pharmaceuticals Overview 5 Key Information 5 Key Facts 5 N30 Pharmaceuticals - Research and Development Overview 6 Key Therapeutic Areas 6 N30 Pharmaceuticals - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 N30 Pharmaceuticals - Pipeline Products Glance 10 N30 Pharmaceuticals Clinical Stage Pipeline Products 10 Phase II Products/Combination Treatment Modalities 10 Phase I Products/Combination Treatment Modalities 11 N30 Pharmaceuticals - Early Stage Pipeline Products 12 Preclinical Products/Combination Treatment Modalities 12 Discovery Products/Combination Treatment Modalities 13 N30 Pharmaceuticals - Drug Profiles 14 N-6000 Series 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 N-6022 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 N-6547 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 N-9000 Series 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 N-91115 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 N-91138 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 N-91169 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 N30 Pharmaceuticals - Pipeline Analysis 21 N30 Pharmaceuticals - Pipeline Products by Therapeutic Class 21 N30 Pharmaceuticals - Pipeline Products By Target 22 N30 Pharmaceuticals - Pipeline Products by Route of Administration 23 N30 Pharmaceuticals - Pipeline Products By Mechanism of Action 24 N30 Pharmaceuticals - Recent Pipeline Updates 25 N30 Pharmaceuticals - Dormant Projects 28 N30 Pharmaceuticals - Locations And Subsidiaries 29 Head Office 29 Appendix 30 Methodology 30 Coverage 30 Secondary Research 30 Primary Research 30 Expert Panel Validation 30 Contact Us 31 Disclaimer 31 About Author Bio: I am working with a market research company which provides market research reports , custom research, company profiles, industry analysis, country reports , business reports, online databases and the report on N30 Pharmaceuticals etc. Through our industry analysis you can identify opportunities, analyze the requirements of the customers and study the competition sector wise.
Related Articles -
Pharmacueticlas and healthcare, N30 Pharmaceuticals,
|
